ADIM
KLIC icon

Alpha DNA Investment Management’s Kulicke & Soffa KLIC Stock Holding History

Alpha DNA Investment Management’s Portfolio KLIC Stock Details KLIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-138
Closed -$6K – 375
2021
Q1 		$6K Buy
138
+96
+229% +$4.17K 0.01% 335
2020
Q4 		$1K Buy
+42
New +$1.22K ﹤0.01% 530

Other funds holding KLIC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Alpha DNA Investment Management's KLIC Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Kulicke & Soffa (KLIC) in Q2 2021, closing a stake of 138 shares — an estimated $6K sold.

Alpha DNA Investment Management first reported a position in KLIC in Q4 2020 and held it in 2 quarters. The position peaked at $6K in Q1 2021. 291 funds tracked by Wall St. Rank hold KLIC as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Kulicke & Soffa position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 138 Kulicke & Soffa shares in Q2 2021, an estimated $6K.
  • Alpha DNA Investment Management first reported a position in Kulicke & Soffa in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Kulicke & Soffa position peaked at $6K in Q1 2021.
  • 291 funds tracked by Wall St. Rank held Kulicke & Soffa as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.